Background: Positive peritoneal cytology (+PCyt) or gross carcinomatosis (GPC)
| INTRODUCTION
Gastric adenocarcinoma (GAC) remains as a global health problem with an estimated 951 600 new cases and 723 100 deaths occurred in 2012. 1 In the United States, the 5 year overall survival rate for GAC is 30.4% and decreases to 5% for advanced stage disease. 2 Accurate baseline staging is essential in order to decide for the most appropriate treatment strategy. 3 Clinical staging of GAC has greatly improved in the recent years with endoscopic ultrasonography (EUS), positron emission tomography (PET)/computed tomography (CT), and laparoscopy. [4] [5] [6] Without appropriate staging, it is not surprising to diagnose peritoneal carcinomatosis (PC) in some patients who are being treated with a curative intent. 7 Laparoscopic staging can detect radiologically occult PC and is recommended for all ≥T1b GACs. 3 In a large study reported by investigators at the Memorial Sloan Kettering Cancer Center, 23% of 657 patients with GAC were found to have M1 disease at baseline staging laparoscopy. 8 The peritoneal disease rate detected with laparoscopy was 32.1% in our institution. 9 In this study, 711 patients with radiologically occult PC were included. At laparoscopy, 148 (20.8%) patients had been found to have macroscopic PC. Among 514 patients without macroscopic PC, cytological analysis of peritoneal lavage was positive in 68 (13.2%) and was equivocal in 12 (2.3%)
patients. In a smaller study from the United Kingdom, 20 of 100 patients were diagnosed with PC or distant metastases (DM) at laparoscopy.
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Gross peritoneal carcinomatosis (GPC) and positive peritoneal cytology (+PCyt) represent M1 GAC and patients with these features have a poor overall survival (OS). [11] [12] [13] The development of PC has a poor prognosis and quality of life. In a recent study by Ikoma et al, 14 of 292 patients who received preoperative therapy 36 patients developed subsequent PC as the common recurrence site (49% of all recurrences). Baseline laparoscopy information in this study is vaguely stated and was not done in every patient. Despite the development of new drugs and new methods to apply these drugs, there is no effective therapy for PC. The outcome of patients with PC differs according to the burden of disease. 15 If the +PCyt can be converted to −PCyt, patients tend to live longer. 12, 16 This suggests that early detection of PC may be useful to develop novel therapeutic interventions. To best of our knowledge, ours is the first analysis looking at subsequent development of PC when baseline laparoscopy was negative.
In this study, we aimed to characterize the natural history of patients with a −PCyt at diagnosis. The OS follow-up was carried out through electronic health records, tumor registry, or the Social Security Database.
| Statistical analysis
Summary statistics were used to describe the overall population and patients that developed PC. OS was calculated as the number of months from the date of diagnosis to death or lost to follow-up.
FIGURE 1
Risk of peritoneal recurrence in potentially resectable gastric adenocarcinoma patients with negative peritoneal cytology at staging 
| RESULTS
Of 238 patients, 46 did not undergo surgery (patient preference, n = 14, comorbidities and poor performance status, n = 15, and evidence of metastases at restaging, n = 17 [eight of whom had PC]) (Figure 1) . The other 192 patients went to surgery. At surgery, 14 out of 192 patients (7.3 %) were found to have M1 GAC (13 patients with PC and one with liver metastases). Of 178 patients with completed surgery, 14 had an R1 and 164 had an R0 resection. We evaluated the clinical course of these 164 patients with R0 resection (Figure 1 ). 
| Patient characteristics

| Overall survival
The median follow-up time was The PC rate was 50% for 14 patients with an R1 resection (Figure 1 ).
| Variables associated with PC recurrence after neoadjuvant therapy and subsequent R0 surgery
The results of the uni-and multi-variate analyses associated with PC are summarized in Table 2 . Female gender was significantly associated with PC after R0 resection in uni-(P < 0.001) and multi-variate FIGURE 2 Kaplan-Meier estimates of overall survival by having peritoneal recurrence or not (patients with negative peritoneal staging at diagnosis and had an R0 surgery, n = 164) FIGURE 3 Kaplan-Meier estimates of overall survival by having peritoneal recurrence (PC), other organ recurrences and patients with no recurrence (patients with negative peritoneal staging at diagnosis and had an R0 surgery, n = 164) Significant p values (p < 0.05) are given in bold.
(P = 0.009) analyses. The PC rate was 25.8% for females and 5.9% for males. Gastric (non-GEJ) location, signet ring cell histology, poor differentiation, and diffuse histology were significantly associated with PC in uni-variate but not multi-variate analysis.
| DISCUSSION
We report that in patients with localized GAC, even if the baseline assessment is −PCyt, the development of PC is ∼25% (with about 7% within 5 months of therapy) and the clinical variables associated with PC are not different than previously reported, however, in this setting, there has not been a report published.
19-21
Lorenzen et al 22 developed +PCyt. Although, this cohort is very small and the conversion rate is low, there may be a benefit of performing another laparoscopic staging just prior to surgery. In our cohort, a total of 21 out of 238 patients (8.8%) were diagnosed with PC at surgery (that is immediately after preoperative therapy). Since the median OS of these patients was only 7 months, an argument can be made that a second laparoscopic staging could be considered prior to surgery in all patients. In Japanese Gastric Cancer Treatment Guidelines, laparoscopic staging is recommended just before surgery. 23 We report an overall 23.5% PC rate for patients with −PCyt at initial staging. Even for the best subgroup that had preoperative therapy followed by R0 resection, the PC rate was 13.4%. The reason for PC after an R0 surgery remains unclear. In two studies from Japan, surgical manipulation was identified as the cause for PC. 24, 25 In the present study, we noted a significantly lower OS rate for patients with PC compared to patients with other organ relapses or those without any relapse. These OS rates are in concordance with that in other studies. 26, 27 Female gender, gastric primary, presence of signet ring cell histology, poor differentiation of tumor, and diffuse histology were associated with PC. In their study, D'Angelica et al 21 also showed an association between PC and female gender, advanced T-stage, distal, and diffuse type tumor. The high PC rate in female gender can be explained by the high frequency of diffuse type gastric cancer in females. 28 To the best of our knowledge, our study is the first study to document the natural history of GAC patients with −PCyt at staging and have an R0
resection. Our data should be interpreted with caution since it is a retrospective series from a single institution. However, our patient cohort is large and homogenously treated. These data will allow us to design new prospective studies that can help to predict the occurrence of PC.
In conclusion, with baseline −PCyt subsequent development of peritoneal recurrence is ∼25% for localized GAC patients and even ∼15% for the favorable group that had preoperative therapy and R0 
